Medication optimization isn’t about just adding medications to a patient’s regimen but also deprescribing medications as needed. There are negative health impacts of polypharmacy, and an interdisciplinary approach is required to address polypharmacy issues.

PQA has several quality measures which address polypharmacy. During this Quality Essentials webinar, Carolyn Lockwood, RN, MSN, Director, Performance Measurement, and Razanne Oueini, PharmD, Senior Manager, Performance Measurement, will provide background on the risks of polypharmacy in older adults, and will describe related PQA measures that address polypharmacy in this population:
• Polypharmacy: Use of Multiple Anticholinergic Medications in Older Adults (POLY-ACH)
• Polypharmacy: Use of Multiple CNS-Active Medications in Older Adults (POLY-CNS)

Speakers from Kaiser Permanente will join to share results and best practices from a deprescribing initiative to reduce polypharmacy in southern California.

Register now!